Burroughs Wellcome Co.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
 
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 3151
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
 
 
A62B DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING 235
 
 
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 163
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
 
 
C07K PEPTIDES 1135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7098006 Chimeric antibody, pharmaceutical composition and process of its productionJun 02, 95Aug 29, 06[C12N]
5681830 Opioid compoundsAug 03, 94Oct 28, 97[A61K, C07D]
5658908 Opioid diarylmethylpiperazines and piperdinesAug 03, 94Aug 19, 97[A61K, C07D]
5644036 Purified immunoglobulinOct 07, 94Jul 01, 97[C07K]
5561164 Method of treatng protozoal infections caused by microsporidiaJun 09, 95Oct 01, 96[A61K]
5547664 Expression of recombinant proteins in attenuated bacteriaDec 12, 94Aug 20, 96[A61K, C12N]
5534535 Therapeutic nucleosidesSep 09, 94Jul 09, 96[A61K, C07D]
5512269 Method of treating retained pulmonary secretionsJun 09, 93Apr 30, 96[A61K]
5495944 Bottle with tamper evident wrappingOct 14, 94Mar 05, 96[B65B]
5466711 MedicamentsMay 20, 92Nov 14, 95[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2007/0212,753 Altered antibodies and their preparationAbandonedApr 26, 05Sep 13, 07[C07H, A61K, C12P, C12N, C07K]
2003/0175,296 Chimaeric hepadnavirus core antigen proteinsAbandonedSep 23, 02Sep 18, 03[A61K, C12N]
6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequenceExpiredNov 19, 93Jan 08, 02[C07H, C12N]
5817652 Hypolipidaemic condensed 1,4-thiazepinesExpiredAug 15, 95Oct 06, 98[A61K, C07D]
5723458 Hypolipidaemic compoundsExpiredAug 15, 95Mar 03, 98[A61K, C07D]
5670482 Neuropeptide Y antagonistsExpiredFeb 17, 95Sep 23, 97[A61K]
5663165 Hypolipidaemic benzothiazepine compoundsExpiredDec 05, 94Sep 02, 97[A61K, C07D]
D376847 Pharmaceutical tabletExpiredDec 21, 92Dec 24, 96[]
5547976 Further indole derivatives with antiviral activityExpiredAug 23, 94Aug 20, 96[A61K, C07D]
5508310 Immunopotentiatory agents and physiologically acceptable salts thereofExpiredMay 19, 95Apr 16, 96[A61K]
5461072 Use of aryl hydroxyurea compounds for the treatment of atherosclerosisExpiredOct 17, 94Oct 24, 95[A01N]
5459158 Pharmaceutical compositions of indazoles and methods of use thereofExpiredDec 17, 93Oct 17, 95[A61K]
5447956 Treatment of leukemia with a imidazo carbamateExpiredJul 08, 94Sep 05, 95[A61K]
5432166 Use of 1-(.beta.-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterolExpiredFeb 11, 93Jul 11, 95[A61K, C07H]
5422373 Anti-atherosclerotic aryl compoundsExpiredMar 23, 93Jun 06, 95[A61K, C07C]
5420115 Method for the treatment of protoza infections with 2.sup.1 -deoxy-2.sup.1 -fluoropurine nucleosidesExpiredSep 02, 92May 30, 95[A61K, C07H]
5420156 Pharmacologically active compound and useExpiredDec 08, 93May 30, 95[A61K, C07D]
5416091 Agents for potentiating the effects of antitumor agents and combating multiple drug resistanceExpiredAug 11, 93May 16, 95[A61K]
5405872 Anti-hypertensive tetralinsExpiredMar 22, 93Apr 11, 95[A61K]
5405850 Antiviral compositions consisting of acyclovir and a 2-acetyl pyridine derivativeExpiredOct 29, 92Apr 11, 95[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.